APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 217 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $972 | -63.8% | 25,581 | -13.1% | 0.01% | -66.7% |
Q2 2023 | $2,683 | +38.2% | 29,441 | 0.0% | 0.02% | +28.6% |
Q1 2023 | $1,942 | +21.8% | 29,441 | -4.6% | 0.01% | +16.7% |
Q4 2022 | $1,595 | -99.9% | 30,846 | -16.8% | 0.01% | -40.0% |
Q3 2022 | $2,530,000 | +51.0% | 37,054 | 0.0% | 0.02% | +66.7% |
Q2 2022 | $1,676,000 | -10.9% | 37,054 | 0.0% | 0.01% | +9.1% |
Q1 2022 | $1,882,000 | – | 37,054 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 3,160,000 | $163,403,600 | 25.44% |
Avoro Capital Advisors LLC | 10,625,000 | $549,418,750 | 8.21% |
Logos Global Management LP | 1,350,000 | $69,808,500 | 8.18% |
EcoR1 Capital, LLC | 5,183,431 | $268,035,217 | 8.16% |
Saturn V Capital Management LP | 212,329 | $9,414,319 | 7.81% |
ACUTA CAPITAL PARTNERS, LLC | 217,500 | $11,246,925 | 6.92% |
Ghost Tree Capital, LLC | 300,000 | $15,513,000 | 6.62% |
Finepoint Capital LP | 334,890 | $17,317 | 5.60% |
Cormorant Asset Management, LP | 1,576,872 | $81,540 | 5.46% |
Tri Locum Partners LP | 221,897 | $11,474,000 | 4.64% |